Today's diagnostic tests are too inefficient to deal with endemic infectious disease. The recent pandemic shows that conventional tests have not been able to contain the spread of outbreaks.
At Dianox, we capture insights from breakthrough biotechnologies to develop user friendly diagnostic self-tests. Our platform is based on deep biotechnology and allows us to detect several bacteria and viruses in saliva.
Our biotechnology consists of synthetic molecules in the form of single-stranded DNA folded into complex 3D structures. These artificially engineered molecules can bind with high affinity and specificity to pre-determined targets. A colorimetric reporter is attached to the molecules to provide a distinct visual test result.
Synthetic molecules can be designed for any target, including toxic or non-immunogenic ones.
Made of nucleotides that give increased binding specificity with picomolar affinity to the target.
10x smaller than antibodies, easy to store, can be modified precisely with high batch-to-batch reproducibility.